Trial Number

275-22

Condition

Head & Neck Cancer

Participant Age Range

65 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

“A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC (NANORAY-312)”

This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy/performance and safety of NBTXR3/RT±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with LA-HNSCC.

Provider

Randy L Wei, MD

Radiation Oncology
Long Beach, Fountain Valley
View Profile

Location

Long Beach Medical Center

2801 Atlantic Avenue
Long Beach
(562) 933-2000
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Long Beach Medical Center
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.